• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CVRX, INC. BAROSTIM NEO2; IMPLANTABLE PULSE GENERATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CVRX, INC. BAROSTIM NEO2; IMPLANTABLE PULSE GENERATOR Back to Search Results
Model Number 2104
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Transient Ischemic Attack (2109)
Event Date 03/24/2023
Event Type  Injury  
Manufacturer Narrative
The results of the investigation are inconclusive at this time, and the reported device was not returned for analysis.Based on the information received, the cause of the reported event could not be conclusively determined.The device history and sterilization record for this device serial number has been reviewed.No issues or discrepancies were noted during this review that would have contributed to the reported event.The device met material, assembly, and quality control requirements.Cvrx id# (b)(4).
 
Event Description
A barostim implant occurred on (b)(6) 2023.The patient habitually took baby aspirin but no other blood thinners, and had held all medications the morning of (b)(6) 2023 as instructed.The procedure was performed successfully without incident, and the patient was stable throughout the procedure.The patient recovered in the pacu and was released home several hours later.In the evening of (b)(6) 2023, the patient experienced a facial droop on the right side of their face and returned to the hospital and was admitted.Imaging did not find any sign of embolism, and no surgical intervention was performed.In the opinion of the physician, the patient experienced a transient ischemic attack (tia), and expects a full recovery.The patient experienced a hematoma and edema at the csl incision.As of (b)(6) 2023, the edema had resolved and the right mouth droop was improved but not yet resolved.An mri was planned.
 
Manufacturer Narrative
Cvrx id#: (b)(4).
 
Event Description
A barostim implant occurred on (b)(6) 2023.The patient habitually took baby aspirin but no other blood thinners, and had held all medications the morning of (b)(6) 2023 as instructed.A carotid ultrasound showed the left side had no stenosis.The procedure was performed successfully on the left carotid without incident, and the patient was stable throughout the procedure.The patient recovered in the pacu and was released home several hours later.In the evening of (b)(6) 2023, the patient experienced a facial droop on the right side of their face and returned to the hospital and was admitted.Imaging did not find any sign of embolism, and no surgical intervention was performed.In the opinion of the physician, the patient experienced a transient ischemic attack (tia), and expects a full recovery.The patient experienced a hematoma and edema at the csl incision.As of (b)(6) 2023, the edema had resolved and, as of (b)(6) 2023, the right mouth droop was improved but not yet resolved.It was noted the barostim therapy had been increased several times with no issues experienced by the patient.
 
Manufacturer Narrative
Cvrx id#: (b)(4).
 
Event Description
A barostim implant occurred on (b)(6) 2023.The patient habitually took baby aspirin but no other blood thinners, and had held all medications the morning of on (b)(6) 2023 as instructed.A carotid ultrasound showed the left side had no stenosis.The procedure was performed successfully on the left carotid without incident, and the patient was stable throughout the procedure.The patient recovered in the pacu and was released home several hours later.In the evening of on (b)(6) 2023, the patient experienced a facial droop on the right side of their face and returned to the hospital and was admitted.Imaging did not find any sign of embolism, and no surgical intervention was performed.In the opinion of the physician, the patient experienced a transient ischemic attack (tia), and expects a full recovery.The patient experienced a hematoma and edema at the csl incision.As of on (b)(6) 2023, the edema had resolved and, as of on (b)(6) 2023, the right mouth droop was improved but not yet resolved.It was noted the barostim therapy had been increased several times with no issues experienced by the patient.As of on (b)(6)2023, the mouth droop had not resolved.The patient had an mri and there were no findings of a stroke.As there were no findings on the mri, the opinion of the physician was that the root cause of the mouth droop was unable to be determined.As of on (b)(6)2023, the mouth droop had not resolved, but the patient was doing well and had more energy.The hematoma had also resolved at an unknown date.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BAROSTIM NEO2
Type of Device
IMPLANTABLE PULSE GENERATOR
Manufacturer (Section D)
CVRX, INC.
9201 west broadway avenue
suite 650
minneapolis MN 55445
Manufacturer (Section G)
CVRX, INC.
9201 west broadway avenue
suite 650
minneapolis MN 55445
Manufacturer Contact
sarah hicks
9201 west broadway avenue
suite 650
minneapolis, MN 55445
MDR Report Key16764102
MDR Text Key313529582
Report Number3007972010-2023-00012
Device Sequence Number1
Product Code DSR
UDI-Device Identifier00859144004623
UDI-Public(01)00859144004623(17)241115
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180050
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 06/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/18/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number2104
Device Catalogue Number100065-202
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/05/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/15/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age72 YR
Patient SexMale
Patient Weight91 KG
-
-